Literature DB >> 26522891

[Epidemiology and clinical characteristics of primary congenital glaucoma].

A Aziz1, O Fakhoury2, F Matonti3, E Pieri2, D Denis2.   

Abstract

INTRODUCTION: Primary congenital glaucoma (PCG) is a rare and sight threatening condition. Few large epidemiological studies are available in the literature concerning this condition. The purpose of the study was to evaluate the epidemiological and clinical characteristics of children affected by PCG. PATIENTS AND
METHOD: Children affected by PCG, from 1 day to 3 years old at the time of diagnosis were retrospectively included between 1999 and 2014. The analysis concerned the pregnancy, family history, initial referral, clinical presentation with description of the classic findings in this condition, mean age at first consultation, duration of follow-up and presence of a delay in treatment, defined as a delay of over one month from the appearance of clinical signs until diagnosis. Two groups were defined according to age at appearance of the clinical signs: "early" group prior to 2 months old and "late" group beyond 2 months up until 3 years old.
RESULTS: One hundred and forty-one eyes of 71 children were included, with 49.3% girls (n=35 children) and 50.7% boys (n=36 children) for a male:female ratio of 1.02. The "early" group included 50 children i.e. 70.3% of the population; the "late" group 21 children or 29.7% of the population. A first-degree family history of congenital glaucoma existed in 28% of cases (n=19). The average age at first consultation was 13.1 months for the entire population, and the mean duration of follow-up was 56.6 months. Involvement was bilateral in 99.3% of cases (n=70 children) and the most frequent clinical sign was buphthalmos in 64.5% of eyes (n=91 eyes). Treatment was delayed in 35.3% of cases (n=25 children). DISCUSSION AND
CONCLUSION: This study is of particular relevance because it was performed over a long period and on a large population, considering the rare prevalence of the pathology, and has found epidemiological and clinical data comparable with those available in the literature for similar populations.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Caractéristiques cliniques; Child; Clinical characteristics; Congenital; Congénital; Enfant; Epidemiology; Glaucoma; Glaucome; Épidémiologie

Mesh:

Year:  2015        PMID: 26522891     DOI: 10.1016/j.jfo.2015.04.018

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  6 in total

1.  The Prevalence of Glaucoma in Young People.

Authors:  Susanne Marx-Gross; Dagmar Laubert-Reh; Astrid Schneider; René Höhn; Alireza Mirshahi; Thomas Münzel; Philipp S Wild; Manfred E Beutel; Maria Blettner; Norbert Pfeiffer
Journal:  Dtsch Arztebl Int       Date:  2017-03-24       Impact factor: 5.594

2.  Fellow Eye in Unilateral Primary Congenital Glaucoma.

Authors:  Nader Hl Bayoumi
Journal:  J Curr Glaucoma Pract       Date:  2017-01-18

3.  The Epidemiological and Clinical Findings from the Latvian Registry of Primary Congenital Glaucoma and Evaluation of Prognostic Factors.

Authors:  Eva Elksne; Kristine Baumane; Arturs Ozolins; Sandra Valeina
Journal:  Medicina (Kaunas)       Date:  2021-01-07       Impact factor: 2.430

4.  Successful Management of Complex Rhegmatogenous Retinal Detachment in Congenital Glaucoma.

Authors:  Suzie Gasparian; Moises Enghelberg; Kakarla V Chalam
Journal:  Cureus       Date:  2021-11-10

5.  Postnatal eye size in mice is controlled by SREBP2-mediated transcriptional repression of Lrp2 and Bmp2.

Authors:  Shuyi Mai; Xiaoxuan Zhu; Esther Yi Ching Wan; Shengyu Wu; Jesslyn Nagalin Yonathan; Jun Wang; Ying Li; Jessica Yuen Wuen Ma; Bing Zuo; Dennis Yan-Yin Tse; Pui-Chi Lo; Xin Wang; Kui Ming Chan; David M Wu; Wenjun Xiong
Journal:  Development       Date:  2022-07-14       Impact factor: 6.862

6.  Ab Interno Goniotomy Combined with Ab Externo Trabeculotomy in Advanced Primary Congenital Glaucoma Patients: 2-Year Follow-Up.

Authors:  Hazem Helmy
Journal:  Clin Ophthalmol       Date:  2021-02-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.